Paul Sargeant, PhD, CEO of Circular Genomics Presents at LSI USA '25 - "Circular RNA Biomarkers for Depression Treatment"

News

1 day ago

Circular Genomics Strengthens Scientific Advisory Board with Addition of Alzheimer's Disease Expert

Press releases

Mar 19

Circular Genomics Joins Lilly Gateway Labs in San Diego to Develop Its Best-In-Class Circular RNA Platform for the Diagnosis and Prognosis of Alzheimer's Disease

Press releases

Mar 17

5 Promising RNA Biotech Companies To Watch in 2025

News

Mar 13

Podcast: "Revolutionizing Depression Treatment with Dr. Nikolaos Mellios"

News

Jan 14

Podcast: "How Do I Know My Antidepressants Are Working?"

News

Jan 14

Precision Psychiatry: A Paradigm Shift for Mental Healthcare

News

Nov 12, 2024

Bringing precision medicine to psychiatry: circular RNAs as a window into the brain

News

Nov 5, 2024

Circular Genomics launches antidepressant response test

News

Sep 17, 2024

Circular Genomics Announces Launch of MindLight™, the First SSRI Antidepressant Response Test Using Brain-Derived Biomarkers

Press releases

Sep 16, 2024

How Circular Genomics is using genetics to stop depression meds being a guessing game

News

Aug 6, 2024

Circular Genomics Announces New Research Demonstrating Accuracy of circRNA-based Test for Predicting Response to SSRI Antidepressant Treatment

Press releases

May 7, 2024

Circular Genomics Adds Dr. Michael Ackermann, PhD, MBA to its Scientific Advisory Board

Press releases

Mar 18, 2024

Circular Genomics Strengthens Leadership Team with Key Commercial and Research Hires

Press releases

Feb 26, 2024

Circular Genomics Raises $8.3 Million for Debut of Circular RNA Assay in Precision Psychiatry

Press releases

Jan 24, 2024